Is Maternal Serum Homocysteine a Novel Diagnostic Biomarker for Predicting Placenta-Mediated Disorders?

Background Uteroplacental insufficiency and related disorders, though a significant cause of undesirable maternal and fetal outcomes, are complex and poorly understood. The newer screening modalities are expensive and difficult to procure for day-to-day use in developing countries. This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramesh, Pooja, Sumathy, Sudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924433/
https://www.ncbi.nlm.nih.gov/pubmed/36793824
http://dx.doi.org/10.7759/cureus.33768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924433/
https://www.ncbi.nlm.nih.gov/pubmed/36793824
http://dx.doi.org/10.7759/cureus.33768

Ejemplares similares